Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA
A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
New MND Early Diagnostic Test: a 'Game-Changer' for Research on the Disease
Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research
Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Speech-Analysis Tool for the Early Detection of Alzheimer's Handed to Linus Health in Acquisition
Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
Abcam: Cancer Biomarkers Guide
Merck: Analyte Quarterly
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Biologics 2024: 13 - 15 March 2024, London, UK
Amita Datta-Mannan
Associate Vice President, Exploratory Medicine and Pharmacology,
Eli Lilly & Company
Erik Vernet
Senior Director - External Partnerships,
Novo Nordisk
Fernando Albericio
Research professor,
Ukzn
Rebecca Croasdale-Wood
Director Augmented Biologics Discovery and Design,
AstraZeneca
Soraya Hölper
Project Lead,
Sanofi
thierry besson
scientist,
novartis
All Speakers
Adrian Torres
Head of R&D,
Aptadel Therapeutics
Alastair Lawson
Vice President and Immunology Fellow,
UCB
Alethea Tabor
Professor of Chemical Biology,
UCL
Alex Zwetsloot
Scientific Investigator,
GSK
Andreas Bernkop-Schnürch
Professor,
Innsbruck University
Andrew Livingston
Professor,
Queen Mary University of London
Arwyn Jones
Professor of Membrane Traffic and Drug Delivery,
Cardiff University
Bryce Nelson
Head protein and antibody engineering,
Orion
Carly Dix
Associate Director,
AstraZeneca
Catalin Nistor
Director Pharmaceutical Research & Early Dev,
Camurus AB
Celine Amara
Project Expert,
Sanofi
.jpg?length=600&name=1af033d7-2b06-4291-9746-3e93caeff828-2-11764368speaker_photo-Christian-Rohlff-OXFORD-BIOTHERAPEUTICS-1013-R-(29).jpg)
Christian Rohlff
Chief Executive Officer,
Oxford Biotherapeutics
Christian Reichen
PhD,
Molecular Partners AG
Christopher Hart
Chief Executive Officer,
Creyon Bio
Cleo Kontoravdi
Professor of Biological Systems Engineering,
Imperial College London
Darko Skegro
Associate Director,
Novartis
.jpg?length=600&name=4630f23f-8dcb-4d1f-b9d8-efb4ca75654d-2-11764368speaker_photo-David-Portrait-in-suit-(2).jpg)
David Evans
Head Discovery,
Sirnaomics
Dimitri Bieli
Executive Vice President Molecular Biology,
Mabylon
Emma Jenkins
Director,
Alchemab Therapeutics
Filippo Sladojevich
Senior Principal Scientist,
Hoffmann-La Roche
Hilmar Ebersbach
Senior Vice President,
Immunos Therapeutics
Horst Bierau
Associate Director - Head CMC Science & Intelligence,
Merck KgaA
Ian Hamley
Professor of Physical Chemistry,
University of Reading
Immanuel Lerner
Chief Executive Officer,
Pepticom
Jacob Kofoed
Principal Scientist,
Novo Nordisk
Jitka Riedl
Associate Principal Scientist,
Bicycle Therapeutics
Joël Richard
Chief Development Officer,
Enterome
Jonathan Hall
Professor,
ETH Zurich
Lars Nieba
Chief Executive Officer,
Engimmune Therapeutics AG
Louis Diorazio
Senior Principal Scientist,
AstraZeneca
.jpg?length=600&name=f79782cc-491c-47a7-a121-1ba433e0254f-2-11764368speaker_photo-Lukasz_Kielpinski-(1).jpg)
Lukasz Kielpinski
Senior Principle Scientist,
Roche
Mahendra Deonarain
Chief Executive Officer,
Antikor
Mark Bushell
Director of Technology,
Maxion Therapeutics
Martin Münzel
Scientific Director,
Novo Nordisk
Massimo Domenico Sammito
Associate Principal Scientist,
AstraZeneca
Mattias Levin
Director, Antibody Technology Innovation,
Alligator Bioscience
Michael Gutknecht
Pricipal Scientist II,
Novartis Pharma AG
Nesrine Chakroun
Senior Scientist,
Merus NV
Oliver Hartley
Vice President Drug Discovery,
Orion Biotechnology
Patrick Schindler
Principle Scientist,
Novartis
Paul Dalby
Professor,
University College London
Poonam Vaghela
Scientist,
Scancell
Rajesh Sundaresan
Scientific Leader,
GSK
Rajika Perera
Chief Executive Officer,
Poseidon LLC
Rob Boyd
Vice President, R&D,
Elasmogen
Rodrigo Ochoa
Senior Scientist,
Novo Nordisk
Samuel Pine
Global Head of Bioanalysis & Immunogenicity, Drug Metabolism and Pharmacokinetics,
Sanofi
Sandor Batkai
Head of Medical Research and Intelligence,
Cardior Pharmaceuticals GmbH
Sandra Prior
Principal Scientist,
Mhra
Shirley Peters
Senior Group Leader,
UCB
Shwana Braim
Lecturer,
Nottingham Trent university
Silvia Crescioli
Independent consultant,
The Antibody Society
Simon Chell
Vice President, Biologics Engineering,
AstraZeneca
Simone Mester
Chief Executive Officer,
Authera
Sophia Karagiannis
Professor of Translational Cancer Immunology and Immunotherapy,
King's College London
.png?length=600&name=e86b147a-eab8-4e9a-9afb-a923a1f46e0a-2-11764368speaker_photo-FullSizeRender_(1).png)
Talip Ucar
Senior Director - AI Research,
AstraZeneca
Thierry Monney
Senior Principal Scientist,
Ichnos Glenmark Innovation
Thomas Nittoli
Senior Director,
Regeneron
Tomas Leek
Director,
AstraZeneca
Trevor Wattam
Associate Director,
Glaxosmithkline
Ulrike Philippar
Vice President, Global Head Discovery,
Johnson & Johnson
Vikash Reebye
Senior Principal Scientist,
MiNA Therapeutics
Vincent Madelain
Servier,
Pharmacometrician
Vladimir Gligorijevic
Senior Director of AI/ML,
Genentech
Will Lewis
Director,
GSK
Yi Yang
Principal Scientist,
Ferring Pharmaceuticals A/S
Yingnan Zhang
Senior Principal Scientific Manager,
Genentech